tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
Holding SLXN?
Track your performance easily

Silexion Therapeutics (SLXN) Technical Analysis

76 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Silexion Therapeutics’s (SLXN) Moving Averages Convergence Divergence (MACD) indicator is -0.28, suggesting Silexion Therapeutics is a Sell.
Silexion Therapeutics’s (SLXN) 20-Day exponential moving average is 1.60, while Silexion Therapeutics’s (SLXN) share price is $3.14, making it a Buy.
Silexion Therapeutics’s (SLXN) 50-Day exponential moving average is 3.33, while Silexion Therapeutics’s (SLXN) share price is $3.14, making it a Sell.

Silexion Therapeutics (SLXN) Pivot Points

Jan 31, 2025, 06:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.49
0.74
1.05
1.30
1.61
1.86
2.17
Fibonacci
0.74
0.96
1.09
1.30
1.52
1.65
1.86
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Silexion Therapeutics (SLXN) Moving Averages

Jan 31, 2025, 06:52 AM
Period
Simple
Exponential
MA5
1.28Buy
1.67Buy
MA10
1.13Buy
1.45Buy
MA20
1.58Buy
1.60Buy
MA50
2.24Buy
3.33Sell
MA100
3.48Sell
13.49Sell
MA200
47.95Sell
44.92Sell
Silexion Therapeutics’s (SLXN) 10-Day exponential moving average is 1.45, while Silexion Therapeutics’s (SLXN) share price is $3.14, making it a Buy.
Silexion Therapeutics’s (SLXN) 100-Day exponential moving average is 13.49, while Silexion Therapeutics’s (SLXN) share price is $3.14, making it a Sell.
Silexion Therapeutics’s (SLXN) stock price is $3.14 and Silexion Therapeutics’s (SLXN) 50-day simple moving average is 2.24, creating a Buy signal.
Silexion Therapeutics’s (SLXN) stock price is $3.14 and Silexion Therapeutics’s (SLXN) 100-day simple moving average is 3.48, creating a Sell signal.
Silexion Therapeutics’s (SLXN) stock price is $3.14 and Silexion Therapeutics’s (SLXN) 200-day simple moving average is 47.95, creating a Sell signal.

Silexion Therapeutics (SLXN) Technical Indicators

Jan 31, 2025, 06:52 AM
Name
Value
Implied Action
RSI (14)
66.88
Neutral
STOCH (9,6)
50.78
Neutral
STOCHRSI (14)
44.22
Neutral
MACD (12,26)
-0.28
Sell
ADX (14)
21.76
Neutral
Williams %R
-10.78
Sell
CCI (14)
137.92
Sell
ATR (14)
0.47
-
Ultimate Oscillator
63.80
Neutral
ROC
49.52
Buy
Silexion Therapeutics’s (SLXN) Relative Strength Index (RSI) is 66.88, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Trend Strength Indicator (ADX) is 21.76, creating a Neutral signal.
Silexion Therapeutics’s (SLXN) Commodity Channel Index (CCI) is 137.92, creating a Sell signal.
Silexion Therapeutics’s (SLXN) Price Rate of Change (ROC) is 49.52, creating a Buy signal.

FAQ

Is SLXN a Buy, Hold, or Sell?
Based on SLXN’s technical indicators, SLXN is a Hold.
    What is SLXN’s RSI (14)?
    SLXN’s RSI (14) is 66.88, which suggests SLXN is a Neutral.
      What is SLXN’s MACD?
      SLXN’s MACD is -0.28, which suggests SLXN is a Sell.
        What is SLXN’s 5-day moving average?
        SLXN’s 5-day moving average is 1.28, which suggests SLXN is a Buy.
          What is SLXN’s 20-day moving average?
          SLXN 20-day moving average is 1.58, which suggests SLXN is a Buy.
            What is SLXN’s 50-day moving average?
            SLXN’s 50-day moving average is 2.24, which suggests SLXN is a Buy.
              What is SLXN’s 200-day moving average?
              SLXN’s 200-day moving average is 47.95, which suggests SLXN is a Sell.
                What is SLXN’s Williams % R (14)?
                SLXN’s Williams % R (14) is -10.78, which suggests SLXN is a Sell.
                  What is SLXN’s CCI (14)?
                  SLXN’s CCI (14) is 137.92, which suggests SLXN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis